Double-Blind, Randomized, Multiple-Dose, Placebo-Controlled, 2-Way Crossover Study To Study Effects Of PF-04457845 On Polysomnographic Endpoints In Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 06 Jul 2010
At a glance
- Drugs PF 4457845 (Primary)
- Indications Pain
- Focus Pharmacodynamics
- Sponsors Pfizer
- 14 Jan 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 14 Jan 2010 Actual patient number (18) added as reported by ClinicalTrials.gov.
- 14 Jan 2010 Planned end date changed from 1 Dec 2009 to 1 Jan 2010 as reported by ClinicalTrials.gov.